Songphol Tungjitviboonkun

4PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 10, 2024
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials.

Songphol Tungjitviboonkun, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon

|Jul 20, 2023
Erlotinib-associated interstitial pneumonitis with successful readministration.

Songphol Tungjitviboonkun, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon

Pageof 1